Convergent Life Sciences, Inc.
Convergent develops efficacious and cost-effective solutions for the accurate detection and targeted treatment of prostate cancer.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location Roseville, CA, USA
- Currency USD
- Website convergentlifesciences.com
Team
-
Amit Vohra, PhDChief Executive OfficerDr. Amit Vohra is the former Vice President of Strategy & Operations of Eigen, where he invented and commercialized the first FDA cleared targeted biopsy and fusion devices. He also held the position of Vice President of Business Development at Advanced Biopharma Consulting.
-
Dan Sperling, MDChairman
Dr. Dan Sperling is the Medical Director and Chief of Radiology at the New Jersey Institute of Radiology. Certified by the American Board of Radiology, Dr. Sperling is an accomplished leader in the diagnosis and treatment of prostate tumors through MRI and laser ablation procedures.
-
Dinesh Kumar, PhDChief Operating Officer & Chief Technology Officer
Dr. Dinesh Kumar is the former Vice President of R&D and Engineering of Eigen, where he invented and commercialized the first FDA cleared targeted biopsy and multi-modality fusion devices. He holds over 15 issued and pending patents.
-
Herbert Lepor, MDChief Medical Officer
Dr. Herbert Lepor is the Chairman of NYU’s Department of Urology, and the Director of the Smilow Comprehensive Prostate Cancer Center. He is the co-founder and editor of Reviews in Urology. Dr. Lepor is a world renowned expert in the field of urology and prostate diseases.
Advisors
-
Latham & Watkins LLP; Ostrolenk Faber LLP (IP)LawyerUnconfirmed
MFA - Moody, Famiglietti & Andronico, LLPAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.